期刊文献+

Doxycycline抑制大肠癌LS174T细胞侵袭的体外实验研究 被引量:3

Effects of Doxycycline on Invasion and Metastasis of Colorectal Cancer Cell Line LS174T
下载PDF
导出
摘要 目的:观察多西环素(Doxycycline)在体外对LS174T侵袭能力的抑制作用,并尝试探讨该抑制作用的分子机制。方法:1)MTT法观察Doxycycline对LS174T细胞粘附力的影响;Transwell小室法检测不同浓度Doxycycline对细胞侵袭和运动能力的抑制作用;2)RT-PCR法检测不同浓度Doxycycline作用48h后,MMP2的mRNA表达情况,同时明胶酶谱法检测MMP2分泌。结果:1)Doxycycline能够以剂量依赖方式抑制大肠癌LS174T细胞的体外运动和侵袭能力,但不影响其粘附能力;2)Doxycycline能够抑制LS174T细胞MMP2的mRNA表达。结论:Doxycycline在体外能够有效地抑制大肠癌LS174T细胞的侵袭、转移,其中MMP2是抑制大肠癌细胞LS174T的一个有效靶点。 Objective: To observe the effects of Doxycycline on matrix metalloproteinase-2 (MMP2) mRNA expression, invasion, and biological activities in the human colorectal cancer cell line LS174T in order to shed light on the molecular mechanism behind Doxycycline's ability to inhibit tumor invasion and metastasis. Methods: a) The effect of Doxycycline on the adhesion activity of LS174T was observed using MTT reduction assay (M3T), and the inhibitory effects on invasion and motility were detected using the Trans-well zeta method, b) RT-PCR was used to detect the mRNA expression of MMP2. At the same, total protein was extracted and used to detect MMP2's gelatinase activity. Results: a) Doxycycline could inhibit the in vitro motility and invasion abilities of the LS174T cells in a dose- dependent manner, with no effect on adhesion, b) Doxycycline could also inhibit the expression of MMP2 mRNA. Conclusion: Doxycycline can effectively inhibit the growth, invasion and metastasis of the LS174T colorectal cancer cells in vitro by inhibiting mRNA expression of MMP2.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2007年第11期625-628,共4页 Chinese Journal of Clinical Oncology
基金 黑龙江省教育厅科学技术研究基金(编号:11511212) 哈尔滨市科技攻关基金资助(编号:106)
关键词 大肠癌LS174T细胞 DOXYCYCLINE 侵袭 转移 金属蛋白酶 Colorectal cell line LS174T Doxycycline Invasion Metastasis Matrix Metalloproteinase
  • 相关文献

参考文献14

二级参考文献106

  • 1[1]Chambers AF,Matrisian LM.Changing view of the role of matrix metalloproteinases in metastasis[J].J Natl Cancer Inst,1997,89(17):1260-1270.
  • 2[2]Gomez DE,Alonso DF,Yoshiji H,et al.Tissue Inhibitors of metalloproteinase structure,regulation and biological functions [J].Eur J cell Biol,1997,74(2)111-122.
  • 3[3]Murray GI,Duncan ME,Arbuckle E,et al.Matrix metalloproteinases and their inhibitors in gastric cancer [J].Gut,1998,43(6):791-797.
  • 4[4]Sier CF,Kubben FJ,Ganesh S,et al.Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma[J].Br J Cancer,1996,74(3):413-417.
  • 5[5]Allgayer H,Babic R,Beyer BC,et al.Prognostic relevance of MMP-2(72-kD collagenase IV) in gastric cancer [J].Oncology,1998,55(2):152-160.
  • 6[6]Koumura H,Sugiyama Y,Kunieda K,et al.Significance in gene expression of matrix metalloproteinase-9 urokinase-type plasminogen activitor and tissue inhibitor of metalloproteinase for metastasis of gastric and/or colorectal cancer[J].Gan To Kagaku Ryoho,1997,24(Suppl 2):324-331.
  • 7[7]Honda M,Mori M,Ueo H,et al.Matrix metalloproteinase-7 expression in gastric carcinoma [J].Gut,1996,39(3):444-448.
  • 8[8]Yamashits K,Azumano I,Mai M,et al.Expression and tissue localization of matrix metalloproteinase7(matrilysin) in human gastric carcinomas.Implications for vessel invasion and metastasis[J].Int J Cancer,1998,79(2):187-194.
  • 9[9]Senota A,Itoh F,Yamamoto H,et al.Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer[J].Clin Exp Metastasis,1998,16(4):313-321.
  • 10[10]Mori M,Mimori K,Shiraishi T,et al.Analysis of MT1-MMP and MMP-2 expression in human gastric cancers[J].Int J Cancer,1997,74(3):316-321.

共引文献196

同被引文献38

  • 1康志强,姜斌,王雅杰.尿激酶型纤溶酶原激活系统与肺癌侵袭转移的关系及靶点治疗的研究[J].肿瘤防治杂志,2004,11(11):1213-1216. 被引量:2
  • 2王晓光,罗荣城.抗肿瘤新生血管靶向治疗进展[J].临床肿瘤学杂志,2006,11(2):155-158. 被引量:7
  • 3程联胜,查昭,席甲甲,江冰,刘兢,姚雪彪.慢病毒介导的RNA干涉对乳腺癌SKBR3细胞HER2受体的下调及生长抑制[J].中国生物工程杂志,2007,27(2):1-8. 被引量:7
  • 4Kim KM, Lee YJ. Role of HER-2/neu signaling in sensitivity to tumor necrosis factor-related apoptosis-inducing ligand: enhancement of TRAIL--mediated apoptosis by amiloride[J]. J Cell Bio- chem, 2005, 96(2):376-389.
  • 5Miternique--Grosse A, Griffon C, Siegel L, et al. Antiangiogenic effects of spironolactone and other potassium-sparing diuretics in human umbilical vein endothelial cells and in fibrin gel chambers implanted in rats[J].J Hypertens, 2006, 24(11): 2207-2213.
  • 6Bauer TW, Liu W, Fan F, et al. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c--Met-- and insulin-like growth factor--I receptor-mediated migration and invasion and orthotopic tumor growth in mice[J]. Cancer Res, 2005, 65(17): 7775-7787.
  • 7De Petro G, Tavian D, Copeta A, et al. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma [J]. Cancer Res, 1998, 58(10):2234-2239.
  • 8Frueh FW, Hayashibara KC, Brown PO, et al. Use of cDNA microarrays to analyze dioxin-induced changes in human liver gene expression[J].Toxicol Lett, 2001, 122(3): 189--203.
  • 9Evans DM, Sloan Stakleff KD. Control of pulmonary metastases of rat mammary cancer by inhibition of uPA and COX-2, singly and in combination[J]. Clin Exp Metastasis, 2004, 21(4): 339-346.
  • 10Tang CH, Hill ML, Brumwell AN, et al. Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with betal integrins [J]. J Cell Sci, 2008, 121(Pt 22) 3747-3756.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部